According to a report from CNN, the American Association of Poison Control Centers, which aggregates data from state poison control centers, found from January to November, there were nearly 3,000 calls involving semaglutide, an increase of more than 15-fold since 2019

A conceptual model of food cue reactivity, Nutrients (2023) Human drug compounding, Food and Drug Administration (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) Your guide to FDA-approved medicines that contain semaglutide, Novo Nordisk FDA alerts health care providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food & Drug Administration (2024) Wegovy, DailyMed (2024) FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded semaglutide drugs, Novo Nordisk (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) OFA v

This is in line with guideline recommendations and with the SmPC, whether taken as a monotherapy or add-on medication [8, 22]
Delayed gastric emptying (slower stomach emptying) Semaglutide delays or slows the movement of food from the stomach to the small intestine
The high-protein group lost more total weight and lost significantly less lean mass